Therapies that cure RESTORE submitted proposal for stage 2
The consortium “RESTORE Health by Advanced Therapies” submitted the proposal for the Large Scale Research Initiative preparatory action phase on September 18, 2018. RESTORE is supported by more than 250 stakeholders from science, industry, non-profit organizations and patient representatives throughout Europe and beyond (USA, Asia), underlining the importance of Ad-vanced Therapies for the scientific and public society.
The European Commission (EC) are creating Large Scale Research Initiative to enable new approaches for coop-erative research in Europe. They are science- and technology-driven, large-scale multidisciplinary research initiatives. The aim is to attract the best scientists and to establish long-term centers of excellence in Europe leading worldwide in their field.
We are grateful to all those, who supported us with their commitment and we are looking optimisti-cally towards the EC decision on 29. November 2018.
The RESTORE founding partners are world leaders from academic and clinical research and in-dustry: BCRT/Charité – Universitätsmedizin Berlin (Germany), University of Zurich (Switzerland), Cell and Gene Therapy Catapult (United Kingdom), TissUse GmbH (Germany), Pluristem Ltd (Isra-el), Miltenyi Biotec GmbH (Germany), INSERM – Institut National de la Santé et de la Recherche (France), Innovation Acta S.r.l. (Italy), Fondazione Telethon Milan and University Minho.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.